In essence, the differing outcomes in these studies emphasize the intricate interplay between genetic variations, environmental factors, and ethnic diversity in shaping the role of HER1–rs11543848 and HER2–rs1136201 polymorphisms in breast cancer susceptibility and clinicopathological characteristics. Here, ERBB2 is linked to breast cancer.